APA (7th ed.) Citation

C, K., P, d. B., J, F., & MJ, F. (2026). MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors. Neuro-oncology advances, 8(Suppl 2), ii14. https://doi.org/10.1093/noajnl/vdae223

Chicago Style (17th ed.) Citation

C, Kotch, de Blank P, Fangusaro J, and Fisher MJ. "MEK Inhibitors for Neurofibromatosis Type 1-associated Central and Peripheral Nervous System Tumors." Neuro-oncology Advances 8, no. Suppl 2 (2026): ii14. https://doi.org/10.1093/noajnl/vdae223.

MLA (9th ed.) Citation

C, Kotch, et al. "MEK Inhibitors for Neurofibromatosis Type 1-associated Central and Peripheral Nervous System Tumors." Neuro-oncology Advances, vol. 8, no. Suppl 2, 2026, p. ii14, https://doi.org/10.1093/noajnl/vdae223.